Ignacio Ruz-Caracuel
Overview
Explore the profile of Ignacio Ruz-Caracuel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
223
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ruz-Caracuel I, Pedraza-Arevalo S, Alonso-Gordoa T, Molina-Cerrillo J, Earl J, Sainz Jr B
Endocr Oncol
. 2025 Jan;
4(1):e240006.
PMID: 39822777
While the role of cancer stem cells (CSCs) in tumorigenesis, chemoresistance, metastasis, and relapse has been extensively studied in solid tumors, such as adenocarcinomas or sarcomas, the same cannot be...
2.
Niedra H, Peculis R, Saksis R, Mandrika I, Vilisova S, Nazarovs J, et al.
Mol Oncol
. 2024 Sep;
19(3):659-681.
PMID: 39245631
Alpha-smooth muscle actin (α-SMA) expression in the stroma is linked to the presence of cancer-associated fibroblasts and is known to correlate with worse outcomes in various tumors. In this study,...
3.
Mendiola M, Heredia-Soto V, Ruz-Caracuel I, Baillo A, Ramon-Patino J, Berjon A, et al.
Mol Cell Probes
. 2024 Jul;
77:101976.
PMID: 39069012
Context: DNA mismatch repair (MMR) deficiency (dMMR) testing is now recommended in endometrial cancer. Defect identification in the molecules participating in this pathway, or the presence of microsatellite instability, are...
4.
Araujo-Castro M, Biagetti B, Torre E, Novoa-Testa I, Cordido F, Pascual-Corrales E, et al.
Endocr Relat Cancer
. 2024 Jul;
31(9).
PMID: 39059428
No abstract available.
5.
Ruz-Caracuel I, Caniego-Casas T, Alonso-Gordoa T, Carretero-Barrio I, Arino-Palao C, Santon A, et al.
Endocr Pathol
. 2024 Jul;
35(3):207-218.
PMID: 38958823
Medullary thyroid carcinoma (MTC) is a rare cancer derived from neuroendocrine C-cells of the thyroid. In contrast to other neuroendocrine tumors, a histological grading system was lacking until recently. A...
6.
Cristina-Marianini-Rios , Sanchez M, Garcia Garcia de Paredes A, Rodriguez M, Barreto E, Lopez J, et al.
Fam Cancer
. 2024 May;
23(3):233-246.
PMID: 38780705
Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related death in the Western world. The number of diagnosed cases and the mortality rate are almost equal as the...
7.
Biagetti B, Araujo-Castro M, Torre E, Novoa-Testa I, Cordido F, Corrales E, et al.
Eur J Endocrinol
. 2024 May;
190(6):458-466.
PMID: 38771697
Objective: The aim of this study is to compare the response to first-line medical treatment in treatment-naive acromegaly patients with pure growth hormone (GH)-secreting pituitary adenoma (GH-PA) and those with...
8.
Lopez-Gil J, Garcia-Silva S, Ruiz-Canas L, Navarro D, Palencia-Campos A, Giraldez-Trujillo A, et al.
Gut
. 2024 May;
73(9):1489-1508.
PMID: 38754953
Objective: Pancreatic ductal adenocarcinoma (PDAC) has limited therapeutic options, particularly with immune checkpoint inhibitors. Highly chemoresistant 'stem-like' cells, known as cancer stem cells (CSCs), are implicated in PDAC aggressiveness. Thus,...
9.
Earl J, Fuentes R, Sanchez M, Garcia Garcia de Paredes A, Munoz M, Sanjuanbenito A, et al.
Fam Cancer
. 2024 May;
23(3):383-392.
PMID: 38753287
The Spanish Familial Pancreatic Cancer Registry (PANGENFAM) was established in 2009 and aims to characterize the genotype and phenotype of familial pancreatic cancer (FPC). Furthermore, an early detection screening program...
10.
Araujo-Castro M, Biagetti B, Torre E, Novoa-Testa I, Cordido F, Pascual-Corrales E, et al.
Endocr Relat Cancer
. 2024 May;
31(7).
PMID: 38713182
The objective of the study was to evaluate the efficacy of second-line therapies in patients with acromegaly caused by a growth hormone (GH) and prolactin (PRL) co-secreting pituitary neuroendocrine tumor...